Mortensen, Rasmus Erik Johansson
Holmström, Morten Orebo http://orcid.org/0000-0002-3764-8578
Andersen, Mads Hald
Funding for this research was provided by:
Sundhedsstyrelsen (4-1612-236/8)
IO Biotech ApS
Article History
Received: 25 August 2021
Accepted: 29 August 2021
First Online: 15 September 2021
Competing interests
: MHA has developed an invention based on the use of TGFβ for vaccinations. The rights of the invention have been transferred to Copenhagen University Hospital Herlev, according to the Danish Law of Public Inventions at Public Research Institutions. The capital region has licensed the rights to the company IO Biotech ApS. The patent application was filed by IO Biotech ApS. MHA is board member, consultant and shareholder in IO Biotech. The other authors declare no competing financial interests.